- Home
- BEDU vs ACET Comparison
BEDU vs ACET Comparison
Compare BEDU & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- ACET
- Stock Information
- Founded
- BEDU 1994
- ACET 1947
- Country
- BEDU United Kingdom
- ACET United States
- Employees
- BEDU N/A
- ACET N/A
- Industry
- BEDU Other Consumer Services
- ACET Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- ACET Health Care
- Exchange
- BEDU Nasdaq
- ACET Nasdaq
- Market Cap
- BEDU 54.0M
- ACET 61.2M
- IPO Year
- BEDU 2017
- ACET N/A
- Fundamental
- Price
- BEDU $1.85
- ACET $0.77
- Analyst Decision
- BEDU
- ACET Strong Buy
- Analyst Count
- BEDU 0
- ACET 7
- Target Price
- BEDU N/A
- ACET $5.60
- AVG Volume (30 Days)
- BEDU 2.3K
- ACET 383.2K
- Earning Date
- BEDU 08-01-2025
- ACET 08-12-2025
- Dividend Yield
- BEDU N/A
- ACET N/A
- EPS Growth
- BEDU N/A
- ACET N/A
- EPS
- BEDU N/A
- ACET N/A
- Revenue
- BEDU $224,321,752.00
- ACET N/A
- Revenue This Year
- BEDU N/A
- ACET N/A
- Revenue Next Year
- BEDU N/A
- ACET N/A
- P/E Ratio
- BEDU N/A
- ACET N/A
- Revenue Growth
- BEDU N/A
- ACET N/A
- 52 Week Low
- BEDU $1.35
- ACET $0.45
- 52 Week High
- BEDU $2.41
- ACET $1.70
- Technical
- Relative Strength Index (RSI)
- BEDU 58.50
- ACET 56.37
- Support Level
- BEDU $1.76
- ACET $0.75
- Resistance Level
- BEDU $1.91
- ACET $0.82
- Average True Range (ATR)
- BEDU 0.05
- ACET 0.05
- MACD
- BEDU 0.01
- ACET 0.01
- Stochastic Oscillator
- BEDU 63.89
- ACET 71.64
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.